Yearly hypertension screening in women with a history of pre-eclampsia: a cost-effectiveness analysis.

ABSTRACT:

Background

Women with a history of preeclampsia are at increased risk for future hypertension and cardiovascular disease (CVD); until now it is not clear whether preventive measures are needed.

Methods

A decision-analytic Markov model was constructed to evaluate healthcare costs and effects of screening and treatment (100 % compliance) for hypertension post preeclampsia based on the available literature. Cardiovascular events and CVD mortality were defined as health states. Outcomes were measured in absolute costs, events, life-years and quality-adjusted life-years (QALYs). Sensitivity and threshold analyses were performed to address uncertainty.

Results

Over a 20-year time horizon, events occurred in 7.2 % of the population after screening, and in 8.5 % of the popula

SUBMITTER: Drost JT 

PROVIDER: S-EPMC4651960 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature